Congress joins fight over rising cost of EpiPens as Shkreli defends | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 24 August, 2016 by The TZ Newswire Staff

Congress joins fight over rising cost of EpiPens as Shkreli defends

Congress is asking for investigations and answers on Mylan’s increase of EpiPen pricing, while the company blames it on Obamacare.
read more

See also
- Next Article The Wall Street Journal: Eric Trump says his father’s tax returns are ‘five feet tall’ and should not be released
- Previous Article Market Extra: On the first anniversary of an ETF freakout, concerns linger
Editorial Calender

August 2016

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

« Jul Sep »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar